Biomarkers Abbr. Specimen Expected values Expected values Measuring range Inflammation Procalcitonin PCT Serum/Whole Blood ·Indicate sepsis and bacterial infection ＜0.05 ng/mL 0.05-100 ng/mL Full Range C-reactive Protein CRP Plasma/Whole Blood ·Low risk of cardiovascular disease ·Medium risk of cardiovascular disease ·High risk of cardiovascular disease ·Detecting conventional inflammation hs-CRP:＜1.0 mg/L hs-CRP: 1.0-3.0 mg/L hs-CRP:＞3.0 mg/L CRP:≦10 mg/L 0.5-200 mg/L C-reactive Protein/Amyloid proteinase A 2-in-1 CRP/SAA Serum/Plasma/Whole Blood ·Low risk of cardiovascular disease ·Medium risk of cardiovascular disease ·High risk of cardiovascular disease ·Identify the type of infection and guide the use of antibiotics hs-CRP:＜1.0 mg/L hs-CRP:1.0-3.0 mg/L hs-CRP:＞3.0 mg/L CRP:≦10 mg/L, SAA:≦6.4 mg/L CRP: 0.5-200 mg/L SAA: 2-220 mg/L Immune Rheumatism 3-in-1 ASO/RF/CRP Serum/Plasma/Whole Blood ·Indicators of systemic inflammation ·To assist in the diagnosis, classification and prognosis of rheumatoid arthritis ASO:≦200 IU/mL RF:≦20 IU/mL CRP:≦10 mg/L ASO:50-500 IU/mL RF:10-200 IU/mL CRF:0.5-200 mg/L *Anti cyclic citrullinated peptide antibody Anti-CCP Serum/Plasma/Whole Blood ·Assistant diagnostic indexe of rheumatoid arthritis ≦25 U/mL 25-1000 U/mL Cardiovascular Cardiac Troponin I cTnI Serum/Plasma/Whole Blood ·Diagnose AMI, risk stratification and evaluate prognosis ·Value markers of non ST segment elevation MI ≦0.3 ng/mL 0.1-50 ng/mL Creatine Kinase-MB CK-MB Serum/Plasma/Whole Blood ·Negative exclusion of early AMI; Detection of recurrence and thrombolytic therapy ≦5 ng/mL 1-100 ng/mL Myoglobin MYO Serum/Plasma/Whole Blood ·Early diagnosis of AMI ≦70 ng/mL 5-500 ng/mL Myocardial Infarction (MI) 3-in-1 cTnI/MYO/ CK-MB Serum/Plasma/Whole Blood ·Same as above 3 markers cTnI:≦0.3 ng/mL MYO:≦70 ng/mL CK-MB:≦5 ng/mL cTnI: 0.1-50 ng/mL MYO: 5-500 ng/mL CK-MB: 1-100 ng/mL D-Dimer（D-Dimer） D-Dimer Plasma/Whole Blood ·Exclusion and diagnosis of venous thromboembolism ≦0.5 mg/L 0.1-10 mg/L N-terminal B-type natriuretic peptide NT-proBNP Serum/Plasma/Whole Blood ·Diagnosis heart failure, risk stratification and prognostic evaluation ≦300 pg/mL 50-35000 pg/mL *Lipoprotein-Associated Phospholipase A2 Lp-PLA2 Serum/Plasma/Whole Blood ·Indicating the stability of atherosclerotic plaque ·Predicting the risk of coronary heart disease and stroke ≦200ng/mL 20-1000 ng/mL *cTnI/NT-proBNP/D-Dimer 3-in-1 cTnI/ NT-proBNP/ D-Dimer Plasma/Whole Blood ·Same as above 3 markers cTnI:≦0.3 ng/mL NT-proBNP:≦300 pg/mL D-Dimer:≦0.5 mg/L cTnI: 0.1-50 ng/mL NT-proBNP: 100-20000 pg/mL D-Dimer: 0.1-10 mg/L Digestion *Pepsinogen I/ Pepsinogen II & 2-in-1 PGI/PGII Serum/Plasma/Whole Blood ·Screening of high risk population of gastric cancer ·Indexes of various gastric functional diseases PGI＜70 ng/mL and PGR (PGI/PGII ratio)＜3.0 PGI: 5-300 ng/mL PGII: 2-70 ng/mL *Gastrin 17 G17 Serum/Plasma/Whole Blood Reflecting both the structure and funtion of the stomach antrum. 1-7 pmol/L 1-50 pmol/L Anaemia Ferritin FER Serum/Plasma/Whole Blood ·One of the diagnostic indexes of invisible iron deficiency anemia and liver disease ·One of malignant tumor markers Male（age 20-60）：30-400 μg/L Female（age 17-60）：13-150 μg/L 5-1000 μg/L Diabetes & Renal Injury β_2-Microglobulin β2-MG Serum/Urine ·Sensitive indicators of crypto acute and chronic kidney diseases ·Detection indexes of various tumors Urine：0.10-0.30mg/L Serum：1.011-2.97mg/L 0.1-20 mg/L Cystatin C Cys-C Serum ·Detection indexes of early diabetic nephropathy and hypertensive nephropathy 0.57-1.01 mg/L 0.2-10 mg/L Neutrophil Gelatinase-Associated Lipocalin NGAL Urine ·Early diagnosis of acute kidney injury (AKI) ＜131.7 ng/mL 5-1500 ng/mL Urine Microalbumin mAlb Urine ·Reflect the situation of early nephropathy and renal injury ≦20 mg/L 5-300mg/mL C-Peptide C-P Serum ·Classification of diabetes mellitus and judgment of islet function 1.1-4.4 ng/mL 0.1-40 ng/mL Glycosylated Hemoglobin HbA1c Whole Blood ·One of the indexes for diagnosis and screening of diabetes mellitus ·Objective to investigate the long-term blood glucose control of diabetic patients 4.0%-6.0% 4.0%-14% Bone Metabolism 25-Hydroxy-Vitamin D 25(OH)VD Serum/Plasma/Whole Blood ·Diagnosis and detection of rickets (children), osteomalacia, postmenopausal osteoporosis and nephropathy ≧30 ng/mL 4-60 ng/mL Fertility *Total β subunit human chorionic gonadotropin β-HCG Serum/Plasma/Whole Blood ·For the diagnosis of early pregnancy. ＜5 mIU/L 5-30000 mIU/L *Progesterone PROG Serum/Plasma/Whole Blood ·Track ovulation and placenta function Male: 0.14-2.06 ng/mL Female Follicular Phase: 0.31-1.52 ng/mL Female Luteal Phase: 5.16-18.56 ng/mL Female Menopause:＜0.78 ng/mL 0.30-40.00 ng/mL Thyroid Hormone *Thyroid-stimulating hormone TSH Serum/Plasma/Whole Blood ·Evaluation of therapeutic effect and prognosis of thyroid diseases 0.51-6.27 mIU/L 0.1-100 mIU/L *Triiodothyronine/Thyroxine  & 2-in-1 TT3/TT4 Serum/Plasma/Whole Blood ·Detection in...

Leading choice for diagnostic department in hospital or laboratories